Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved the combination regimen of Venclexta® (venetoclax) ...

At 33 years old, Kaedi Cecala faced […] ...

First all-oral, fixed-duration combination regimen approved for previously untreated patients with CLL Approval supported by data from the Phase 3 AMPLIFY ...

A bride left wedding guests stunned and many in tears after revealing that the stem cell donor who saved her life was ...

The U.S. Food and Drug Administration (FDA) has approved Filkri (filgrastim-laha), a biosimilar to Neupogen (filgrastim), to ...

In AYAs, the ASH guideline panel recommends pediatric-inspired (asparaginase-containing) regimens for treatment-naïve B-ALL and T-ALL, and blinatumomab for relapsed/refractory B-ALL.

Moffitt Cancer Center is now out of reach for many with Aetna Medicare Advantage HMO and PPO plans, and it will soon be the same for Humana Medicare Advantage HMO and PPO plans.

By the time cancer symptoms appear, the disease has already been developing for years, often leaving subtle clues in routine bloodwork long before diagnosis.

Juan Uribe reached 11.7 million people within 24 hours of posting his plea for help. Now, 10 days later, the video has over 20 million views ...

Skidaway Island resident Bruce Koehler is among early participants seeing clinical blood‑count improvements in a nationwide ...

LUMBERTON — Local music star Rob Cole is hosting a free-to-attend fundraiser concert at Robeson Community College on Saturday ...